
zzso routinely used to treat zzso selectively induce zzso in some tumor cells by zzso the zzso zzso Recent clinical studies suggest that a subset of breast tumors is particularly susceptible to zzso zzso such as zzso To quickly advance statins as effective zzso agents for breast cancer treatment, it is critical to identify the molecular features defining this sensitive zzso We have therefore characterized zzso sensitivity by zzso zzso in a panel of 19 breast cell lines that reflect the molecular diversity of breast cancer, and have evaluated the association of sensitivity with several zzso and molecular zzso A wide range of zzso sensitivity was observed across breast tumor cell lines, with zzso cell death in a subset of sensitive cell zzso zzso sensitivity was associated with an zzso zzso alpha zzso zzso tumor zzso features that can be scored with routine and/or strong zzso zzso To ascertain additional candidate zzso molecular features, we zzso publicly available gene expression zzso identifying zzso regulators of zzso production, zzso zzso zzso and global cellular zzso including the zzso zzso Further exploration of this data allowed us to generate a zzso zzso abundance signature zzso of zzso sensitivity, which showed preliminary validation in an independent set of breast tumor cell zzso Here, we have therefore identified several candidate zzso of sensitivity to zzso treatment in breast cancer, which warrant further zzso and clinical zzso 

